"Oprah's Weight-Loss Revolution: Key Insights and Annoying Remarks"

In Oprah Winfrey's latest special, "Shame, Blame and the Weight Loss Revolution," executives from Novo Nordisk and Eli Lilly discuss the increasing use of weight loss drugs like Ozempic and Zepbound for managing obesity, despite not being FDA-approved for this purpose. They emphasize changing attitudes toward obesity and the need to stop shaming individuals dealing with excess weight. However, access to these drugs can be limited and costly, with out-of-pocket expenses reaching over $1,000 for a monthly supply.